Last reviewed · How we verify

NCT04930341

The Effect of Self-Acupressure Application on Pain, Fatigue and Sleep Quality in Cancer Patients Receiving Chemotherapy

Completed NA Last updated 31 August 2023
What this trial tests

NA trial testing Self-Acupressure in Cancer in 60 participants. Completed in 27 October 2021.

Timeline
15 June 2021
Primary endpoint
27 August 2021
27 October 2021

Quick facts

Lead sponsorIstanbul Sabahattin Zaim University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment60
Start date15 June 2021
Primary completion27 August 2021
Estimated completion27 October 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Sabahattin Zaim University

Who can join

Adults 18 to 65, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to examine the effect of Self-Acupressure application on pain, fatigue and sleep quality in cancer patients receiving chemotherapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Self-Acupressure

Trials testing the same drug.

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Istanbul Sabahattin Zaim University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04930341.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing